The effects of selenium on tumor growth in epithelial ovarian carcinoma

Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in...

Full description

Saved in:
Bibliographic Details
Published inJournal of gynecologic oncology Vol. 23; no. 3; pp. 190 - 196
Main Authors Park, Jin Sun, Ryu, Ji Yoon, Jeon, Hye-Kyung, Cho, Young Jae, Park, Young Ae, Choi, Jung-Joo, Lee, Jeong-Won, Kim, Byoung-Gie, Bae, Duk-Soo
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Gynecologic Oncology and Colposcopy 01.07.2012
대한부인종양학회
Subjects
Online AccessGet full text
ISSN2005-0380
2005-0399
2005-0399
DOI10.3802/jgo.2012.23.3.190

Cover

Abstract Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model. Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice. The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone. Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy.
AbstractList Objective: Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model. Methods: Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice. Results: The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone. Conclusion: Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy. KCI Citation Count: 12
Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model. Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice. The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone. Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy.
Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.OBJECTIVEEpidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.METHODSCell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.RESULTSThe in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy.CONCLUSIONAlthough selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy.
Author Park, Jin Sun
Lee, Jeong-Won
Cho, Young Jae
Bae, Duk-Soo
Choi, Jung-Joo
Ryu, Ji Yoon
Jeon, Hye-Kyung
Park, Young Ae
Kim, Byoung-Gie
AuthorAffiliation Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Jin Sun
  surname: Park
  fullname: Park, Jin Sun
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 2
  givenname: Ji Yoon
  surname: Ryu
  fullname: Ryu, Ji Yoon
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 3
  givenname: Hye-Kyung
  surname: Jeon
  fullname: Jeon, Hye-Kyung
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 4
  givenname: Young Jae
  surname: Cho
  fullname: Cho, Young Jae
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 5
  givenname: Young Ae
  surname: Park
  fullname: Park, Young Ae
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 6
  givenname: Jung-Joo
  surname: Choi
  fullname: Choi, Jung-Joo
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 7
  givenname: Jeong-Won
  surname: Lee
  fullname: Lee, Jeong-Won
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 8
  givenname: Byoung-Gie
  surname: Kim
  fullname: Kim, Byoung-Gie
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 9
  givenname: Duk-Soo
  surname: Bae
  fullname: Bae, Duk-Soo
  organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22808362$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001681468$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkUFP3DAQha0KVGDpD-il8rGXTcd27MSXSgi1gIRUqVrOluOd7BoSO7UTEP--2S6FtodyGkt-z9-85xNyEGJAQt4zKEQN_NPtJhYcGC-4KETBNLwhxxxALkFoffB8ruGInOR8C6AqqPlbcsR5DbVQ_JhcrLZIsW3RjZnGlmbsMPippzHQcepjopsUH8Yt9YHi4Mctdt52NN7b5G2gzibnQ-ztKTlsbZfx3dNckJuvX1bnl8vrbxdX52fXS1cKPi5RgCxrJZtKthaRV4rbslLYyBIbxXijta51A3Jez62VrNaqtU3Jag1MlXYtFuTj_t2QWnPnvInW_5qbaO6SOfu-ujKiVCWDWcr30ikM9vHBdp0Zku9tejQMzK5AMxdodgUaLowwc4Gz6fPeNExNj2uHYUz2xbij_X0T_HZm3xshtAQmXxYcUvwxYR5N77PDrrMB45RnNK-gZHwOuCAf_mQ9Q37_ziyo9gKXYs4JW-P8aEcfd2jf_TcG-8f5evSfPxe0Xg
CitedBy_id crossref_primary_10_1016_j_matlet_2019_126590
crossref_primary_10_1021_acsnano_6b03835
crossref_primary_10_3802_jgo_2013_24_1_96
crossref_primary_10_3389_fbioe_2023_1252816
crossref_primary_10_1039_c3mt00002h
crossref_primary_10_3390_ijms24031918
crossref_primary_10_1007_s11356_015_5960_y
crossref_primary_10_3892_ijo_2015_2968
crossref_primary_10_18632_oncotarget_8619
crossref_primary_10_1016_j_jnutbio_2014_09_013
crossref_primary_10_3802_jgo_2013_24_1_97
crossref_primary_10_1016_j_cbi_2014_12_016
Cites_doi 10.1200/JCO.2006.07.9970
10.1016/S0163-7258(98)00014-X
10.1016/j.tiv.2009.07.012
10.1093/jnci/92.24.2018
10.1016/j.mehy.2006.01.058
10.1007/BF02785304
10.1158/1535-7163.MCT-06-0400
10.1016/j.ygyno.2003.12.013
10.1089/ars.2007.1528
10.1016/j.colsurfb.2008.07.010
10.1093/jnci/87.7.497
10.1158/1535-7163.877.3.7
10.1007/s002800000127
10.1158/0008-5472.CAN-05-2216
10.1016/j.ijrobp.2008.07.005
10.1016/j.bcp.2003.09.021
10.1016/S1535-6108(04)00002-9
10.1158/1078-0432.CCR-03-0268
10.1093/carcin/20.9.1657
10.1097/01.ju.0000092859.16817.8e
10.1038/sj.bjc.6601974
10.1038/sj.ejcn.1600902
10.1002/jcb.20755
10.1016/S0022-5347(05)65500-0
10.1001/jama.1996.03540240035027
10.1038/emm.2004.22
10.1158/1078-0432.CCR-08-2966
10.1093/jnci/djh125
10.1079/BJN20031015
10.1093/jnci/djp231
10.1093/ajcn/79.1.80
10.1093/jnci/90.16.1219
ContentType Journal Article
Copyright Copyright © 2012. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology 2012
Copyright_xml – notice: Copyright © 2012. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology 2012
DBID AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.3802/jgo.2012.23.3.190
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-0399
EndPage 196
ExternalDocumentID oai_kci_go_kr_ARTI_346410
10.3802/jgo.2012.23.3.190
PMC3395015
22808362
10_3802_jgo_2012_23_3_190
Genre Journal Article
GroupedDBID 29K
2WC
5-W
53G
5GY
8JR
8XY
9ZL
AAKDD
AAYXX
ABDBF
ACUHS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
D-I
DIK
DU5
E3Z
EBD
EF.
F5P
GROUPED_DOAJ
HYE
HZB
OK1
RPM
M~E
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
ID FETCH-LOGICAL-c432t-e3054865b75faee2762a476eb54eb612b99989b05083cd657d6fab41890164ad3
IEDL.DBID UNPAY
ISSN 2005-0380
2005-0399
IngestDate Tue Nov 21 21:47:11 EST 2023
Tue Aug 19 20:45:59 EDT 2025
Thu Aug 21 13:51:22 EDT 2025
Wed Oct 01 13:32:06 EDT 2025
Thu Jan 02 22:10:16 EST 2025
Tue Jul 01 02:37:27 EDT 2025
Thu Apr 24 23:00:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Sodium selenite
Cell survival
Ovarian carcinoma
Tumor growth
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c432t-e3054865b75faee2762a476eb54eb612b99989b05083cd657d6fab41890164ad3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Both authors contributed equally.
G704-001660.2012.23.3.013
OpenAccessLink https://proxy.k.utb.cz/login?url=http://synapse.koreamed.org/Synapse/Data/PDFData/1114JGO/jgo-23-190.pdf
PMID 22808362
PQID 1027041208
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_346410
unpaywall_primary_10_3802_jgo_2012_23_3_190
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3395015
proquest_miscellaneous_1027041208
pubmed_primary_22808362
crossref_citationtrail_10_3802_jgo_2012_23_3_190
crossref_primary_10_3802_jgo_2012_23_3_190
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-07-01
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: 2012-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of gynecologic oncology
PublicationTitleAlternate J Gynecol Oncol
PublicationYear 2012
Publisher Korean Society of Gynecologic Oncology and Colposcopy
대한부인종양학회
Publisher_xml – name: Korean Society of Gynecologic Oncology and Colposcopy
– name: 대한부인종양학회
References Kralova (10.3802/jgo.2012.23.3.190_ref27) 2009; 23
Clark (10.3802/jgo.2012.23.3.190_ref3) 1996; 276
Li (10.3802/jgo.2012.23.3.190_ref9) 2004; 96
Combs (10.3802/jgo.2012.23.3.190_ref23) 2004; 91
Yoshizawa (10.3802/jgo.2012.23.3.190_ref11) 1998; 90
Lee (10.3802/jgo.2012.23.3.190_ref19) 2009; 15
Jonsson-Videsater (10.3802/jgo.2012.23.3.190_ref26) 2004; 67
Ozols (10.3802/jgo.2012.23.3.190_ref2) 2004; 5
Lee (10.3802/jgo.2012.23.3.190_ref20) 2009; 101
Caffrey (10.3802/jgo.2012.23.3.190_ref21) 2000; 46
Sieja (10.3802/jgo.2012.23.3.190_ref35) 2004; 93
Zhao (10.3802/jgo.2012.23.3.190_ref30) 2006; 5
Mannisto (10.3802/jgo.2012.23.3.190_ref4) 2000; 54
Helzlsouer (10.3802/jgo.2012.23.3.190_ref8) 2000; 92
Zhong (10.3802/jgo.2012.23.3.190_ref28) 2001; 61
Garland (10.3802/jgo.2012.23.3.190_ref5) 1995; 87
Kim (10.3802/jgo.2012.23.3.190_ref18) 2004; 36
Landen (10.3802/jgo.2012.23.3.190_ref1) 2008; 26
Han (10.3802/jgo.2012.23.3.190_ref25) 2007; 40
Chen (10.3802/jgo.2012.23.3.190_ref15) 2008; 67
Hu (10.3802/jgo.2012.23.3.190_ref34) 1997; 56
Whanger (10.3802/jgo.2012.23.3.190_ref24) 2004; 91
Cao (10.3802/jgo.2012.23.3.190_ref31) 2004; 10
Combs (10.3802/jgo.2012.23.3.190_ref22) 1998; 79
Papp (10.3802/jgo.2012.23.3.190_ref12) 2007; 9
Wei (10.3802/jgo.2012.23.3.190_ref6) 2004; 79
Ganther (10.3802/jgo.2012.23.3.190_ref13) 1999; 20
Bhattacharyya (10.3802/jgo.2012.23.3.190_ref33) 2008; 72
Jiang (10.3802/jgo.2012.23.3.190_ref17) 2004; 3
Dong (10.3802/jgo.2012.23.3.190_ref16) 2006; 98
Drake (10.3802/jgo.2012.23.3.190_ref14) 2006; 67
Zhao (10.3802/jgo.2012.23.3.190_ref29) 2006; 66
Corcoran (10.3802/jgo.2012.23.3.190_ref32) 2004; 171
Nomura (10.3802/jgo.2012.23.3.190_ref10) 2000; 9
Brooks (10.3802/jgo.2012.23.3.190_ref7) 2001; 166
11585738 - Cancer Res. 2001 Oct 1;61(19):7071-8
14684401 - Am J Clin Nutr. 2004 Jan;79(1):80-5
19351748 - Clin Cancer Res. 2009 Apr 15;15(8):2695-702
18805679 - Colloids Surf B Biointerfaces. 2008 Nov 15;67(1):26-31
15252149 - Mol Cancer Ther. 2004 Jul;3(7):877-84
14749123 - Cancer Cell. 2004 Jan;5(1):19-24
14713851 - J Urol. 2004 Feb;171(2 Pt 1):907-10
16574336 - Med Hypotheses. 2006;67(2):318-22
10694779 - Eur J Clin Nutr. 2000 Feb;54(2):98-103
10469608 - Carcinogenesis. 1999 Sep;20(9):1657-66
15037203 - Biochem Pharmacol. 2004 Feb 1;67(3):513-22
15099940 - Gynecol Oncol. 2004 May;93(2):320-7
7707436 - J Natl Cancer Inst. 1995 Apr 5;87(7):497-505
19641174 - J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205
14748935 - Br J Nutr. 2004 Jan;91(1):11-28
19602434 - Toxicol In Vitro. 2009 Dec;23(8):1497-503
18760546 - Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40
11696701 - J Urol. 2001 Dec;166(6):2034-8
9197929 - Biol Trace Elem Res. 1997 Mar;56(3):331-41
17172431 - Mol Cancer Ther. 2006 Dec;5(12):3275-84
15150444 - Exp Mol Med. 2004 Apr 30;36(2):157-64
18195328 - J Clin Oncol. 2008 Feb 20;26(6):995-1005
11121464 - J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23
16552729 - J Cell Biochem. 2006 Aug 15;98(6):1495-506
15126606 - J Natl Cancer Inst. 2004 May 5;96(9):696-703
10912582 - Cancer Chemother Pharmacol. 2000;46(1):74-8
17394769 - J Biochem Mol Biol. 2007 Mar 31;40(2):196-204
16489034 - Cancer Res. 2006 Feb 15;66(4):2296-304
15073137 - Clin Cancer Res. 2004 Apr 1;10(7):2561-9
9719083 - J Natl Cancer Inst. 1998 Aug 19;90(16):1219-24
11008904 - Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7
9776375 - Pharmacol Ther. 1998 Sep;79(3):179-92
8971064 - JAMA. 1996 Dec 25;276(24):1957-63
15213714 - Br J Cancer. 2004 Jul 19;91(2):195-9
17508906 - Antioxid Redox Signal. 2007 Jul;9(7):775-806
References_xml – volume: 26
  start-page: 995
  year: 2008
  ident: 10.3802/jgo.2012.23.3.190_ref1
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.07.9970
– volume: 9
  start-page: 883
  year: 2000
  ident: 10.3802/jgo.2012.23.3.190_ref10
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 79
  start-page: 179
  year: 1998
  ident: 10.3802/jgo.2012.23.3.190_ref22
  publication-title: Pharmacol Ther
  doi: 10.1016/S0163-7258(98)00014-X
– volume: 23
  start-page: 1497
  year: 2009
  ident: 10.3802/jgo.2012.23.3.190_ref27
  publication-title: Toxicol In Vitro
  doi: 10.1016/j.tiv.2009.07.012
– volume: 92
  start-page: 2018
  year: 2000
  ident: 10.3802/jgo.2012.23.3.190_ref8
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/92.24.2018
– volume: 67
  start-page: 318
  year: 2006
  ident: 10.3802/jgo.2012.23.3.190_ref14
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2006.01.058
– volume: 56
  start-page: 331
  year: 1997
  ident: 10.3802/jgo.2012.23.3.190_ref34
  publication-title: Biol Trace Elem Res
  doi: 10.1007/BF02785304
– volume: 5
  start-page: 3275
  year: 2006
  ident: 10.3802/jgo.2012.23.3.190_ref30
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-06-0400
– volume: 93
  start-page: 320
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref35
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2003.12.013
– volume: 9
  start-page: 775
  year: 2007
  ident: 10.3802/jgo.2012.23.3.190_ref12
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2007.1528
– volume: 67
  start-page: 26
  year: 2008
  ident: 10.3802/jgo.2012.23.3.190_ref15
  publication-title: Colloids Surf B Biointerfaces
  doi: 10.1016/j.colsurfb.2008.07.010
– volume: 87
  start-page: 497
  year: 1995
  ident: 10.3802/jgo.2012.23.3.190_ref5
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/87.7.497
– volume: 3
  start-page: 877
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref17
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.877.3.7
– volume: 46
  start-page: 74
  year: 2000
  ident: 10.3802/jgo.2012.23.3.190_ref21
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s002800000127
– volume: 66
  start-page: 2296
  year: 2006
  ident: 10.3802/jgo.2012.23.3.190_ref29
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2216
– volume: 72
  start-page: 935
  year: 2008
  ident: 10.3802/jgo.2012.23.3.190_ref33
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.07.005
– volume: 67
  start-page: 513
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref26
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2003.09.021
– volume: 5
  start-page: 19
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref2
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(04)00002-9
– volume: 10
  start-page: 2561
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref31
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-03-0268
– volume: 20
  start-page: 1657
  year: 1999
  ident: 10.3802/jgo.2012.23.3.190_ref13
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/20.9.1657
– volume: 61
  start-page: 7071
  year: 2001
  ident: 10.3802/jgo.2012.23.3.190_ref28
  publication-title: Cancer Res
– volume: 171
  start-page: 907
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref32
  publication-title: J Urol
  doi: 10.1097/01.ju.0000092859.16817.8e
– volume: 91
  start-page: 195
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref23
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601974
– volume: 54
  start-page: 98
  year: 2000
  ident: 10.3802/jgo.2012.23.3.190_ref4
  publication-title: Eur J Clin Nutr
  doi: 10.1038/sj.ejcn.1600902
– volume: 98
  start-page: 1495
  year: 2006
  ident: 10.3802/jgo.2012.23.3.190_ref16
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.20755
– volume: 166
  start-page: 2034
  year: 2001
  ident: 10.3802/jgo.2012.23.3.190_ref7
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)65500-0
– volume: 276
  start-page: 1957
  year: 1996
  ident: 10.3802/jgo.2012.23.3.190_ref3
  publication-title: JAMA
  doi: 10.1001/jama.1996.03540240035027
– volume: 36
  start-page: 157
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref18
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2004.22
– volume: 15
  start-page: 2695
  year: 2009
  ident: 10.3802/jgo.2012.23.3.190_ref19
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-2966
– volume: 96
  start-page: 696
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref9
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djh125
– volume: 91
  start-page: 11
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref24
  publication-title: Br J Nutr
  doi: 10.1079/BJN20031015
– volume: 101
  start-page: 1193
  year: 2009
  ident: 10.3802/jgo.2012.23.3.190_ref20
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djp231
– volume: 40
  start-page: 196
  year: 2007
  ident: 10.3802/jgo.2012.23.3.190_ref25
  publication-title: J Biochem Mol Biol
– volume: 79
  start-page: 80
  year: 2004
  ident: 10.3802/jgo.2012.23.3.190_ref6
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.1.80
– volume: 90
  start-page: 1219
  year: 1998
  ident: 10.3802/jgo.2012.23.3.190_ref11
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/90.16.1219
– reference: 18805679 - Colloids Surf B Biointerfaces. 2008 Nov 15;67(1):26-31
– reference: 7707436 - J Natl Cancer Inst. 1995 Apr 5;87(7):497-505
– reference: 17508906 - Antioxid Redox Signal. 2007 Jul;9(7):775-806
– reference: 9776375 - Pharmacol Ther. 1998 Sep;79(3):179-92
– reference: 15252149 - Mol Cancer Ther. 2004 Jul;3(7):877-84
– reference: 14749123 - Cancer Cell. 2004 Jan;5(1):19-24
– reference: 14684401 - Am J Clin Nutr. 2004 Jan;79(1):80-5
– reference: 9719083 - J Natl Cancer Inst. 1998 Aug 19;90(16):1219-24
– reference: 15126606 - J Natl Cancer Inst. 2004 May 5;96(9):696-703
– reference: 18195328 - J Clin Oncol. 2008 Feb 20;26(6):995-1005
– reference: 11696701 - J Urol. 2001 Dec;166(6):2034-8
– reference: 11585738 - Cancer Res. 2001 Oct 1;61(19):7071-8
– reference: 10469608 - Carcinogenesis. 1999 Sep;20(9):1657-66
– reference: 11008904 - Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7
– reference: 10694779 - Eur J Clin Nutr. 2000 Feb;54(2):98-103
– reference: 11121464 - J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23
– reference: 15099940 - Gynecol Oncol. 2004 May;93(2):320-7
– reference: 17172431 - Mol Cancer Ther. 2006 Dec;5(12):3275-84
– reference: 18760546 - Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40
– reference: 9197929 - Biol Trace Elem Res. 1997 Mar;56(3):331-41
– reference: 19602434 - Toxicol In Vitro. 2009 Dec;23(8):1497-503
– reference: 16489034 - Cancer Res. 2006 Feb 15;66(4):2296-304
– reference: 8971064 - JAMA. 1996 Dec 25;276(24):1957-63
– reference: 15213714 - Br J Cancer. 2004 Jul 19;91(2):195-9
– reference: 14713851 - J Urol. 2004 Feb;171(2 Pt 1):907-10
– reference: 10912582 - Cancer Chemother Pharmacol. 2000;46(1):74-8
– reference: 15150444 - Exp Mol Med. 2004 Apr 30;36(2):157-64
– reference: 19351748 - Clin Cancer Res. 2009 Apr 15;15(8):2695-702
– reference: 19641174 - J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205
– reference: 16552729 - J Cell Biochem. 2006 Aug 15;98(6):1495-506
– reference: 17394769 - J Biochem Mol Biol. 2007 Mar 31;40(2):196-204
– reference: 16574336 - Med Hypotheses. 2006;67(2):318-22
– reference: 15073137 - Clin Cancer Res. 2004 Apr 1;10(7):2561-9
– reference: 15037203 - Biochem Pharmacol. 2004 Feb 1;67(3):513-22
– reference: 14748935 - Br J Nutr. 2004 Jan;91(1):11-28
SSID ssj0067082
Score 1.9576377
Snippet Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere...
Objective: Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to...
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 190
SubjectTerms Original
산부인과학
Title The effects of selenium on tumor growth in epithelial ovarian carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/22808362
https://www.proquest.com/docview/1027041208
https://pubmed.ncbi.nlm.nih.gov/PMC3395015
http://synapse.koreamed.org/Synapse/Data/PDFData/1114JGO/jgo-23-190.pdf
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001681468
UnpaywallVersion publishedVersion
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Gynecologic Oncology, 2012, 23(3), , pp.190-196
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2005-0399
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067082
  issn: 2005-0399
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2005-0399
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067082
  issn: 2005-0399
  databaseCode: ABDBF
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2005-0399
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067082
  issn: 2005-0399
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-0399
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067082
  issn: 2005-0399
  databaseCode: 5-W
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2005-0399
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067082
  issn: 2005-0399
  databaseCode: RPM
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELe2TgJexjcLH5OReAIlTWzn63FidGPSxiSoNJ4sx3HW0taJ2gQ0_nrukrTaNARCPCVxLrZsn-2fc-ffEfLG12EcpEXgKq21K0xSuGmSGzePdZ4nPDGhwQPOp2fR8VicXIQXW2QdjHN1ZVW1Mt6sBMgEy0Fry__cJQ4PVa2G54ej9gpjVJwcfRp-uyxdxl1Y17wqL7bJToSWpgHZGZ-dH3zF0HLItenzNoZaf5-mnX0TEhlmgB5ezGPc416Ak_O1FWrbLovfgc_bPpR3G1upqx9qPr-2QI3uk8n6mE_nlzLzmjrz9M_brI__W_cHZLcHsfSg07qHZMvYR-TOaW-mf0yOQPlo7ylCy4JiRCc7bRa0tLRuFuWSXsLuv57QqaWmwlMhcxgGtPwOG3dlqcb4RrZcqCdkPPrw5f2x20dscLXgrHYNzB4iicIsDgtlDIOZVok4MlkoTAZYKgM4mqSZjxz0Oo_COI8KlYkgSZHpS-X8KRnY0po9QlMRM8FVyHQOIC8wGTNFrgPIK44jlYUO8de9JHVPZ45RNeYStjXYsRJaR2LHSsYll9BIDnm7-aTquDz-JPwaul7O9FQiAzdeQWS2lLDP-Ci5iESAMmvFkDAq0dSirCmbFWTLYmQy8xOHPOsUZVMkEhAlgBscEt9QoY0AlnfzjZ1OWuZvztMQ8JtD3m2U7e81ef5P0i_IPXzuPJJfkkG9bMwrwF11tt_-r9jvR9Yv59wqog
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELe2TgJexuegfMlIPIGSJrbz9TgxujFpYxJUGk-WYztraetEbTI0_nrumrTaNARCPDlxLrZsn-2fdeffEfI20FESZkXoKa21J2xaeFlqrGcSbUzKUxtZvOB8chofjcTxeXS-RdbBOJdXTlVL609LgEywHaxs-V_azMGBqtXg7GC4SmGOiuPDz4PvF6XHuAf7ml-ZYpvsxGhp6pGd0enZ_jcMLYdcmwFfxVDrnrOstW9CJsMC0MOL-Yz73A9xcb62Q227RfE78Hnbh_Ju4yp19UPNZtc2qOF9Ml5f82n9UqZ-U-e-_nmb9fF_2_6A7HYglu63WveQbFn3iNw56cz0j8khKB_tPEVoWVCM6OQmzZyWjtbNvFzQCzj912M6cdRWeCtkBtOAlpdwcFeOaoxv5Mq5ekJGw49fPxx5XcQGTwvOas_C6iHSOMqTqFDWMlhplUhim0fC5oClcoCjaZYHyEGvTRwlJi5ULsI0Q6YvZfge6bnS2WeEZiJhgquIaQMgL7Q5s4XRIZSVJLHKoz4J1qMkdUdnjlE1ZhKONTiwEnpH4sBKxiWX0El98m7zS9VyefxJ-A0MvZzqiUQGbkxBZLqQcM74JLmIRYgya8WQMCvR1KKcLZslFMsSZDIL0j552irKpkokIEoBN_RJckOFNgJY380vbjJeMX9znkWA3_rk_UbZ_t6S5_8k_YLcw_fWI_kl6dWLxr4C3FXnr7s59QvtzCmt
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+selenium+on+tumor+growth+in+epithelial+ovarian+carcinoma&rft.jtitle=Journal+of+gynecologic+oncology&rft.au=Park%2C+Jin+Sun&rft.au=Ryu%2C+Ji+Yoon&rft.au=Jeon%2C+Hye-Kyung&rft.au=Cho%2C+Young+Jae&rft.date=2012-07-01&rft.eissn=2005-0399&rft.volume=23&rft.issue=3&rft.spage=190&rft_id=info:doi/10.3802%2Fjgo.2012.23.3.190&rft_id=info%3Apmid%2F22808362&rft.externalDocID=22808362
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-0380&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-0380&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-0380&client=summon